Example: tourism industry
Revised AEFI Guidelines: Executive Summary
Causality Assessment is the systematic evaluation of the information obtained about an AEFI to determine the likelihood of the event having been caused by the vaccine/s received. It is a critical part of AEFI monitoring and enhances confidence in the national immunization programme. The revised guidelines use the new revised WHO/CIOMS Causality ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
National Guidelines for Engagement of Housekeeping ...
main.mohfw.gov.in12. assessment of cleanliness and quality control (1) 61 13. cleaning standards 65 elements (26) 65 14.1 building elements 65 14.2 fixture elements 66 14.3 equipment elements 68 14.4 environmental elements 68 14. occupational health and safety (1) 70 15. evaluation of bids for outsourcing of sanitation services 72
CANCER PREVENTION AND CONTROL IN INDIA
main.mohfw.gov.inCancer prevention and treatment strategies for India India is the one of the few developing countries that has formulated a National Cancer Control Programme. The programme envisages control of tobacco related cancers; early diagnosis and treatment of uterine cervical cancer; and distribution of therapy services, pain relief and
Universal Immunization Program
main.mohfw.gov.incommitment towards measles elimination and rubella/congenital rubella syndrome (CRS) control by 2020. 2014: No Wild Polio virus case was reported from the country for the last three years and India had a historic achievement and was certified as “polio free country” along with other South East Asia Region (SEAR) countries of WHO.
ELECTRONIC HEALTH RECORD
main.mohfw.gov.instandards in EHR/EMR and other similar clinical information systems. The scope is limited to identifying the standards, their intended purposes in such systems, followed by a short guideline-for-implementation ... and have fully integrated and always available health records in an electronic format is not only empowering
NATIONAL PROGRAMMES UNDER NRHM
main.mohfw.gov.inLumefantrine (ACT-AL) has been recommended for the treatment of Pf cases in the North Eastern States. For strengthening surveillance, Rapid Diagnostic Test (RDT) for diagnosis of P.falciparum malaria has also been introduced in high endemic areas and being scaled up. Considering that about 50% of the malaria cases are due
Government of India
main.mohfw.gov.inwelfare and emerging issues in this area. NFHS-5 data will be useful in setting benchmarks and examining ... survey; and the ownership and use of mosquito nets. The Woman’s Schedule covered a wide variety of topics, including the woman’s characteristics, marriage, fertility, contraception, children’s immunizations and ...
DELHI
main.mohfw.gov.inDepartment, Ahmedabad Yellow Fever Vaccination enter, Sardar Patel havan, Ahmedabad Municipal orporation Head Office, Ground Floor, Danapith, Ahmedabad-1 Dr. Amit egda Tuesday & Thursday 11:00 AM – 5:00 PM 079-25391811 Extn.- 698 5 Guru Gobind Singh Govt. Hospital, Gujarat Pandit Nehru Marg Jamnagar-361008, Gujarat
National Health Accounts Estimates for India
main.mohfw.gov.inNational Health Accounts 2015-16 is the third round of expenditure estimates based on System of Health Accounts 2011. This report is a reflection of Indian's progress towards Universal Health Coverage with a mandate to track healthcare expenditures for evidence based policy and making healthcare accessible, affordable and of better quality. It is
Guidelines for Prevention and Management of Stroke
main.mohfw.gov.in2. Methods of Primary Prevention of Stroke: 2.1 Mass (population-wide) strategy 2.2 High Risk Strategy 3.What are the Gaps in Primary Stroke/ cardiovascular disease (CVD) prevention? Lack of awareness Under usage of population-wide strategies False reassurance of low risk Management of blood pressure
NATIONAL PROGRAMME FOR PREVENTION AND CONTROL …
main.mohfw.gov.inMedical Research (ICMR), it is estimated that there are about 28 lakh cases of different type of Cancers in the country with occurrence of about 11 lakh new ... screening of target population (age 30 years and above,) will be conducted either ... government/municipalities in cities with population of more than 1 million.
Related documents
Pharmacovigilance and Risk Management - Elsevier
www.elsevier.comthe assessment of benefit versus risk must begin during the preclinical evaluation of a medic- ... (causality) to the investigational product, and reported to the regulatory authorities and other stakeholders, either as an expedited report or as part of an aggregate report, based upon ... Adverse drug reaction
The Basics on Adverse Event Monitoring, Assessment and ...
www.bumc.bu.eduthere is a reasonable possibility that the drug caused the adverse event….. _ – ZReasonable possibility: evidence to suggest a causal relationship between the drug and the adverse event. (21 CFR 312.32) •Adverse reaction: Subset of suspected adverse reactions – ^Any adverse event caused by a drug. (FDA Guidance, 12/12) 17 Adverse event
5.3.6 CUMULATIVE ANALYSIS OF POST …
drtrozzi.orgreported from clinical studies regardless of causality assessment. The limitations of post-marketing adverse drug event reporting should be considered when interpreting these data: • Reports are submitted voluntarily, and the magnitude of underreporting is unknown.
WHO | Definitions
www.who.intAdverse reaction WHO, (1972) • 'A response to a drug which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy of disease, or for the modifications of physiological function'.
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euIn accordance with the ICH-E2A guideline, the definition of an adverse reaction implies at least a reasonable possibility of a causal relationship between a suspected medicinal product and an adverse event. An adverse reaction, in contrast to an adverse event, is …
COVID-19 vaccine safety update
www.cdc.govVaccine Adverse Event Reporting System (VAERS) Strengths. National data Rapidly detects safety signals Can detect rare adverse events Data available to public. Limitations. Reporting bias Inconsistent data quality and completeness of information Lack of unvaccinated comparison group Not designed to assess causality ‒ ‒